Implantable Cardiac Monitor Market by Indication (Cardiac Arrhythmias, Atrial Fibrillation, and Epilepsy & Unexplained Falls) and End User [Hospitals, Cardiac Centers & Clinics and Ambulatory Surgical Centers (ASCs)] - Global Opportunity Analysis and Industry Forecast, 2020-2030

Market Definition

The Global Implantable Cardiac Monitor Market was valued at USD 521.41 million in 2019 and is predicted to reach USD 1 billion by 2030 with a CAGR of 6.1% from 2020-2030.

The implantable cardiac monitor is also known as the implantable loop recorder. These are small devices that can be inserted into the human body for continuously monitoring their heart beats. They have the ability to not only monitor but also to evaluate and report the inconsistent and unexplained arrhythmias. The increasing prevalence of cardiac arrhythmias such as atrial fibrillation and bradycardia has boosted the demand for implantable cardiac monitor market globally.

Market Dynamics and Trends

The implantable cardiac monitor eliminates the need for bulky external monitors that require inconvenient wire leads attached to the patient. Technological advancements in cardiac monitor devices have made them easier to be implanted under the skin of the patient’s chest for continuously monitoring their heart and detect cardiac arrhythmias and atrial fibrillation.

Increasing incidences of atrial fibrillation, myocardial infarction, and arrhythmias have been driving the growth of global implantable cardiac monitor market. Also, factors such as durability of implantable cardiac monitors along with other advantages they offer such as reduced duration of hospitalization and lesser readmission requirements are contributing to the growth of this market.

Moreover, investments made by the key players in the R&D to innovate such devices are also supporting the growth of implantable cardiac monitor market. However, the availability of alternative modes of treatments and high cost associated with implantable monitors are hampering the growth of this market to some extent. On the other hand, increased awareness about the advantages of these devices is expected to create new opportunities for market players in the coming future.

Market Segmentations and Scope of the Study:

The implantable cardiac monitor market is segmented into indication, end user and geography. On the basis of indication, the market is segmented into cardiac arrhythmias, atrial fibrillation, epilepsy and unexplained falls. On the basis of end user, the market is segmented into hospitals, cardiac centers & clinics, and ambulatory surgery centers. Based on geography the market is segmented into North America, Europe, Asia Pacific and RoW.

Geographical Analysis:

The North American region is anticipated to hold the lion share of the market during the forecast period. This is attributable to the factors including high adoption rate of technologically advanced implantable cardiac monitors, the presence of major key healthcare companies, high consumer awareness, and favorable reimbursement framework.

However, Asia Pacific region is expected to show rapid and consistent growth in terms of market share within the forecast period owing to factors such as increasing prevalence of atrial fibrillation, rise in obesity, and growing geriatric population.

Competitive Landscape:

Lucrative growth opportunities make the implantable cardiac monitor market extremely competitive. Some of the major players in the market are Abbott Laboratories, Biotronik SE & Co. KG, Boston Scientific Corporation, Edwards Lifescience Corporation, General Electric Company, Koninklijke Philips N.V., LivaNova PLC, Medtronic plc, Nihon Kohden Corporation and Phoenix Heart Center. Strategic alliances, acquisitions and innovations along with R&D are key strategies used by the market players to maintain market dominance.

KEY BENEFITS

• The implantable cardiac monitor report provides the quantitative analysis of the current market and estimations through 2020-2030 that assists in identifying the prevailing market opportunities to capitalize on

• The study comprises a deep dive analysis of the implantable cardiac monitor market trend including the current and future trends for depicting the prevalent investment pockets in the market

• The information related to key drivers, restraints and opportunities and their impact on the implantable cardiac monitor market is provided in the report.

• The market share of the players in the global implantable cardiac monitor market along with their competitive analysis.

• Value chain analysis in the market study provides a clear picture of the stakeholders’ roles.

KEY MARKET SEGMENTS:

By Indication

• Cardiac Arrhythmias

• Atrial Fibrillation

• Epilepsy & Unexplained Falls

By End User

• Hospitals

• Cardiac Centers & Clinics

• Ambulatory Surgical Centers

By Geography

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • Germany

  • France

  • UK

  • Italy

  • Spain

  • Switzerland

  • Rest of Europe

• Asia-Pacific

  • Japan

  • China

  • India 

  • Australia

  • Malaysia

  • New Zealand

  • Rest of Asia-Pacific

• RoW

  • Brazil

  • South Africa

  • Egypt

  • Remaining Countries

REPORT SCOPE AND SEGMENTATION:

Test